Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.940
-0.070 (-1.40%)
At close: Mar 3, 2026, 4:00 PM EST
5.00
+0.06 (1.21%)
Pre-market: Mar 4, 2026, 9:14 AM EST

TriSalus Life Sciences Revenue

TriSalus Life Sciences had revenue of $11.57M in the quarter ending September 30, 2025, with 57.38% growth. This brings the company's revenue in the last twelve months to $40.21M, up 49.52% year-over-year. In the year 2024, TriSalus Life Sciences had annual revenue of $29.43M with 58.99% growth.

Revenue (ttm)
$40.21M
Revenue Growth
+49.52%
P/S Ratio
7.35
Revenue / Employee
$365,518
Employees
110
Market Cap
295.47M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202429.43M10.92M58.99%
Dec 31, 202318.51M6.11M49.31%
Dec 31, 202212.40M4.00M47.58%
Dec 31, 20218.40M2.97M54.60%
Dec 31, 20205.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Viemed Healthcare254.79M
RxSight134.48M
Quanterix130.20M
Owlet99.64M
Delcath Systems85.23M
Sight Sciences76.05M
908 Devices65.05M
ClearPoint Neuro34.33M
Revenue Rankings

TLSI News

More News